# FDA recall D-0929-2017

> **Allergan Sales, LLC** · Class II · drug recall initiated 2017-05-01.

## Product

Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% sterile, 3.5 g tube, RX only, Manufactured by Allergan, Irvine, California, 92612, U.S.A., NDC: 0023-0313-04.

## Reason for recall

Failed Impurities/Degradation Specifications: stability testing results did not meet the specification for impurities.

## Distribution

Nationwide in the US

## Key facts

- **Recall number:** D-0929-2017
- **Recalling firm:** Allergan Sales, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-05-01
- **Report date:** 2017-07-05
- **Termination date:** 2019-05-01

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Waco, TX, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0929-2017

## Citation

> AI Analytics. FDA recall D-0929-2017. Retrieved 2026-06-04 from https://api.ai-analytics.org/recall/D-0929-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*